2015Äê5ÔÂ26ÈÕ£¬ÃÀ¹ú·Éº²×´Ê¦ÊÂÎñËùµÄ×ÊÉî״ʦTom IrvingÏÈÉú¼°Ö£ÐÀÒËŮʿµ½·Ã¿Ê±¡£Á½Î»×´Ê¦ÂÃÐÐÁË×ܳ§ÆóÒµÕ¹Ìü²¢¾Í¡¶ÃÀ¹úרÀûˢз¨°¸¡·ÖС°ÊÚȨºóÖØÉ󡱡¢¡°Ë«·½ÖØÉó¡±³ÌÐò£¬ÒÔ¼°FDA³ÈƤÊéҩƷרÀûÇåÆ¬ÃæµÄÄÚÈÝÓëÆóÒµ¿Æ¼¼Ö°Ô±¾ÙÐÐÁËÉîÈë½»Á÷¡£×ܳ§Ö´·¨ÊÂÎñÓëÉ󼯲¿²¿³¤ÐíÊçÎĽӴýÁËÀ´·Ã¿ÍÈË£¬×ܳ§¡¢»¯Ñ§Ò©³§¡¢´ó¿µ½¡¹«Ë¾µÄÑз¢¡¢ÖªÊ¶²úȨ¡¢Êг¡µÈÏà¹ØÖ°Ô±Ò»Í¬¼ÓÈëÁ˴˴ν»Á÷Ô˶¯¡£
FDAµÄ³ÈƤÊéÊÇÃÀ¹úҽҩרÀûÁ´½ÓÖÆ¶ÈµÄÖ÷Òª×é³É£¬ËüµÄÕýʽÃû³ÆÊÇ£ºAPPROVED DRUG PRODUCTS WITH THERAPEUTIC EQUIVALENCE EVALUATIONS£¨Í¨¹ýµÈЧÐÔÆÀ¹À»ñµÃÅú×¼µÄÒ©Î£¬ÊÕ¼µÄÊÇÃÀ¹úFDAƾ֤Çå¾²ÓëÓÐÓÃÔÔòÊÕ¼µÄËùÓÐÅú×¼Ò©Î°üÀ¨ÐÂÒ©¡¢·ÂÖÆÒ©¡£±¾´Î½»Á÷µ±ÖУ¬TomÏÈÉúÏêϸÏÈÈÝÁË¿ÉÒÔÁÐÈëµ½³ÈƤÊéµ±ÖеÄרÀûÀàÐÍ£¬ÏêϸÓУºÖÊÁÏÒ©£¨»îÐÔÒòËØ¡¢¶à¾§ÐÍÎ¡¢Ò©Îï²úÆ·£¨¼ÁÐͺÍ×éºÏÎ¡¢Àú³ÌÌØÕ÷±íÕ÷µÄвúÆ·¡¢Ò©ÎïʹÓÃÒªÁìµÈ¡£²¢½øÒ»²½½â˵ÔõÑùÌá³öÉêÇë¼°ÌîдÉêÇë±í¸ñʱµÄ×¢ÖØÊÂÏͨ¹ý´Ë´Î½»Á÷£¬ÆóÒµÔ±¹¤¶ÔÃÀ¹úרÀû·¨°¸¼°³ÈƤÊéҩƷרÀûÇåµ¥ÓÐÁËÔ½·¢ÉîÈëµÄÊìϤ£¬ÓÐÀûÓÚÆóÒµ×ÔÖ÷Á¢ÒìÒ©ÎïµÄרÀû±£»¤ÍâÑó½á¹¹ÊÂÇé½øÒ»²½µØ¿ªÕ¹¡£
·Éº²×´Ê¦ÊÂÎñËùÊÇÃÀ¹ú×î´óµÄרÃÅ´ÓÊÂ֪ʶ²úȨ·¨µÄ״ʦÊÂÎñËùÖ®Ò»£¬ÓªÒµÉ漰רÀû¡¢É̱ꡢ°æÈ¨ºÍÉÌÒµÉñÃØ·¨µÄ¸÷¸ö·½Ã棬°üÀ¨×Éѯ¡¢ÉêÇë¡¢ÔÊÐíºÍËßËÏ£¬»¹´ú±í¿Í»§½â¾öÓë¹ú¼ÊÉÌÒµ¡¢ÖªÊ¶²úȨ×éºÏÖÎÀí¡¢»¥ÁªÍø¡¢µç×ÓÉÌÎñ¡¢Õþ¸®ÌõÔ¼¡¢·´Â¢¶ÏºÍ²»Õýµ±¾ºÕùµÈÓйصÄ֪ʶ²úȨ·¨ÎÊÌâ¡£
½üÄêÀ´,×ܳ§ÔÚ֪ʶ²úȨÖÎÀíÖÐÈ¡µÃÁËÓÅÒìЧ¹û¡£2014Äê,×ܳ§Í¨¹ýÁ˹ú¼Ò֪ʶ²úȨÖÎÀíϵͳÉóºËÈÏÖ¤, ÊÇÌìÏÂÊ×Åú¡¢»ªÄϵØÇøÊ×¼Òͨ¹ý֪ʶ²úȨÖÎÀíϵͳÉóºËÈÏÖ¤µÄÒ½Ò©ÆóÒµ£»Í¬Ä꣬¡°Í·æß¿Ëë¿ÊèɢƬ¼°ÆäÖÆ±¸ÒªÁ족»ñµÃÖйúרÀûÓÅÒì½±¡£×ܳ§Æ¾Ö¤ÆóÒµµÄ֪ʶ²úȨսÂÔÔöÇ¿ÁËרÀûµÄÍâÑó½á¹¹£¬ÏȺóÔÚÅ·ÖÞ¡¢ÃÀ¹úµÈµØÇøÉêÇëÁËרÀû²¢»ñµÃÊÚȨ¡£´Ë´Î·Éº²ÂÉËù×ÊÉî״ʦµÄµ½·Ã½»Á÷£¬ÎªÎÒ³§´øÀ´ÁËÃÀ¹úרÀûÉêÇëµÄ×îж¯Ì¬£¬Í¬Ê±¼ÓÉîÁËË«·½µÄ½»Á÷ÏàÖú¡£

2015Äê5ÔÂ26ÈÕ£¬ÔÚÖ´·¨ÊÂÎñÓëÉ󼯲¿²¿³¤ÐíÊçÎĵÄÅãͬÏ£¬
ÃÀ¹ú·Éº²×´Ê¦ÊÂÎñËùµÄ×ÊÉî״ʦTom IrvingÏÈÉú¼°Ö£ÐÀÒËŮʿÂÃÐÐ×ܳ§ÆóÒµÕ¹Ìü

Tom Irving״ʦ½Ìѧ¡°³ÈƤÊ顱ÄÚÈÝ

Ö÷Òª²Î»áÖ°Ô±Óë·Éº²×´Ê¦ÊÂÎñËùµÄ×ÊÉî״ʦºÏÓ°ÁôÄî